Industry / Malaysia

Pharmaniaga Posts Disappointing Financial Results

February 2010 | Industry Trend Analysis

Printable version
Email
Bookmark

Malaysian drugmaker Pharmaniaga 'remains focused on strategies' despite releasing disappointing 2009 financial results. Sales and profit before tax both decreased compared with the previous year.

To read the full article, please sign in or take a free trial.

Related Insight Articles

Outlook Positive For Pharmaniaga Despite Setbacks

Industry / Malaysia Malaysian drugmaker and medicine distributor Pharmaniaga has had a turbulent start to 2010. Following the February release of financial results that BMI described as 'disappointing',[1] the company's...

March 2010

CCM Duopharma To Build 'Fill And Finish' Plant

Industry / Malaysia To boost sales and profit, Malaysian drugmaker CCM Duopharma is looking to export high-value products to neighbouring countries. Given the relatively limited size and growth of the company's domestic...

February 2010

Drugmakers Reminded Of Production Rules

Industry / Malaysia Malaysia's Drug Control Authority (DCA) has reminded pharmaceutical companies to inform it of changes to their production processes. Failure to do so will result in the cancellation of licences and withdrawal...

January 2010

Novartis Looks To Biotech Sector

Companies / Malaysia Swiss drugmaker Novartis may invest in Malaysia's biotechnology industry, after CEO Daniel Vasella reportedly expressed interest during a meeting with the country's Minister for Science, Technology and...

October 2006

Ranbaxy Targets Statins Market

Companies / Malaysia Indian drugmaker Ranbaxy has announced that its' Malaysian subsidiary has launched a generic version of Atorvastatin under the brand name Storvas. The product will be made available though all general...

September 2006